AMYRIAD THERAPEUTICS Trademark

Trademark Overview


On Wednesday, November 3, 2021, a trademark application was filed for AMYRIAD THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the AMYRIAD THERAPEUTICS trademark a serial number of 97107538. The federal status of this trademark filing is SUSPENSION INQUIRY - MAILED as of Wednesday, June 11, 2025. This trademark is owned by AmyriAD Therapeutics B.V.. The AMYRIAD THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals, namely, pharmaceutical preparations to treat neurodegenerative diseases; pharmaceuticals, namely, pharmaceutical preparations to attenuate the accumulation of dysfunctional proteins

Pharmaceutical research and development services; scientific research in the nature of conducting clinical trials in the field of neurodegenerative diseases; scientific research in the nature of conducting clinical trials in the field of dysfunctional protein accumulation; research and development in the field of biotechnology; research and development in the field of biochemistry; information, advisory and consultancy services in relation to all of the foregoing
amyriad therapeutics

General Information


Serial Number97107538
Word MarkAMYRIAD THERAPEUTICS
Filing DateWednesday, November 3, 2021
Status651 - SUSPENSION INQUIRY - MAILED
Status DateWednesday, June 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals, namely, pharmaceutical preparations to treat neurodegenerative diseases; pharmaceuticals, namely, pharmaceutical preparations to attenuate the accumulation of dysfunctional proteins
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development services; scientific research in the nature of conducting clinical trials in the field of neurodegenerative diseases; scientific research in the nature of conducting clinical trials in the field of dysfunctional protein accumulation; research and development in the field of biotechnology; research and development in the field of biochemistry; information, advisory and consultancy services in relation to all of the foregoing

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, November 15, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmyriAD Therapeutics B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLos Angeles, CA 90071

Trademark Events


Event DateEvent Description
Friday, August 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, November 6, 2021NEW APPLICATION ENTERED
Monday, November 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 12, 2022ASSIGNED TO EXAMINER
Friday, August 19, 2022NON-FINAL ACTION WRITTEN
Friday, August 19, 2022NON-FINAL ACTION E-MAILED
Friday, February 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, February 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 27, 2023SUSPENSION LETTER WRITTEN
Monday, February 27, 2023LETTER OF SUSPENSION E-MAILED
Monday, February 27, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 13, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, January 12, 2024ASSIGNED TO EXAMINER
Monday, April 15, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, May 16, 2024NON-FINAL ACTION E-MAILED
Thursday, May 16, 2024NON-FINAL ACTION WRITTEN
Thursday, May 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 14, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, November 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 14, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, December 6, 2024SUSPENSION LETTER WRITTEN
Friday, December 6, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, June 8, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, June 11, 2025INQUIRY TO SUSPENSION E-MAILED
Friday, December 6, 2024LETTER OF SUSPENSION E-MAILED
Wednesday, June 11, 2025SUSPENSION INQUIRY WRITTEN
Wednesday, June 11, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, September 9, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, September 9, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED